Clinical Trials Logo

Tissue Adhesions clinical trials

View clinical trials related to Tissue Adhesions.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04108286 Withdrawn - Visual Acuity Clinical Trials

Ex-vivo Adhesion of Bacteria to Different Contact Lens Materials

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

This is a single-site, 4-visit, contralateral, dispensing, open-label, randomized study. Each eligible subject will be randomized into one of two sequence groups to wear two lens types contralaterally (Test on the right eye and Control on left eye or vice versa).

NCT ID: NCT03825783 Withdrawn - Clinical trials for Leukocyte Adhesion Defect - Type I

A Gene Therapy Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I

Start date: April 15, 2019
Phase: Phase 1
Study type: Interventional

The primary purpose of the Phase I portion of the study is to determine the safety profile and preliminary evidence of efficacy associated with infusion of autologous gene-corrected hematopoietic stem cells.

NCT ID: NCT02382952 Withdrawn - Clinical trials for Blood Loss, Surgical

Pilot Study Differential Dissectorâ„¢ for Blunt Dissection

Start date: March 2015
Phase: N/A
Study type: Interventional

The primary purpose of this study is to evaluate the quality of blunt dissection during abdominal and pelvic surgery involving dissection of adhesions, separation of blood vessels and neurovascular structures while preserving the integrity of these structures.

NCT ID: NCT02001701 Withdrawn - Clinical trials for Vitreomacular Adhesion

Intravitreal Gas for Vitreomacular Adhesion

RELEASE
Start date: November 2013
Phase: N/A
Study type: Interventional

Vitreomacular adhesion causes symptoms of blurry vision, distortion, and double vision. It is due to an abnormal separation of the vitreous gel from the surface of the retina and macula. The current, gold-standard treatment for this condition involves surgery performed in the operating room that involves risk such as bleeding, infection, cataract, and retinal detachment. It has been previously shown that a less invasive intravitreal injection of a gas bubble performed in the office may also treat vitreomacular adhesion with less risk than surgery. The purpose of this study is to determine the effect of an office-based injection of an intravitreal gas bubble as a treatment for symptomatic vitreomacular adhesion.

NCT ID: NCT01971060 Withdrawn - Infertility Clinical Trials

a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy.

VLocmyo
Start date: August 2013
Phase: N/A
Study type: Interventional

Premenopausal Women ages 18-42 will undergo a laparoscopic myomectomy. Prior to the myomectomy, adhesions will be assessed using a modified AFS scoring technique. All investigators will provide usual and customary care to research subjects during the first look laparoscopy. This includes the use of all standard practice anti-adhesive agents and heparinized irrigation fluids.V-Loc 180 suture will be utilized in all patients. All patients will then be evaluated by means of a second look laparoscopy (SLL) 6-12 weeks after the initial surgery and reevaluated via modified American Fertility Society scoring techniques. An independent reviewer will also score adhesions utilize a video recording made from the second look laparoscopic surgery. Patients will be contacted both 1 and 4 weeks post -op and assessed for complications. It is the expectation that patients will show no greater post-operative adhesion formation and a <1% complication rate. Time and ease of suturing will also be evaluated. It is expected that the V-Loc suturing technique will show significantly reduced suturing time, be easier to use, and will be associated with minimal adhesions.

NCT ID: NCT01010464 Withdrawn - Open Abdomen Clinical Trials

An Adhesion Reduction Plan in the Management of the Surgical Open Abdomen

Start date: January 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether an adhesion reduction plan, consisting of early adhesion prevention and application of a bioresorbable membrane is effective in reducing the severity of adhesions and the incidence of complications in managing the open abdomen in trauma and emergency general surgery.